SonoThera

company

Summary
Funding Rounds
Investors
Employees

About

SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound.

San Francisco,California,United States
11 - 50
https://sonothera.com

Highlights

Details

Last Funding Type: Series A
Last Funding Money Raised: $60.75M
Industries: Biopharma,Biotechnology,Genetics,Medical
Founded date: Jan 1, 1982
Number Of Employee: 11 - 50
Operating Status: Active
Legal Name: SonoThera, Inc.

SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound. Its mission is to develop genetic medicines that treat the root cause of human disease.
SonoThera is expanding the possibilities of disease treatment with ultrasound-guided nonviral gene therapy for diseases with suboptimal or non-existent treatments. It aims to improve the lives and health of millions of people.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

$60.75M

SonoThera has raised a total of $60.75M in funding over 2 rounds. Their latest funding was raised on Dec 5, 2022 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 5, 2022	Series A	$60.75M	11	ARCH Venture Partners	—	Detail

Investors

Number of Lead Investors

Number of Investors

SonoThera is funded by 11 investors. ARCH Venture Partners and Alexandria Venture Investments are the most recent investors.

Investor Name	Lead Investor	Funding Round
ARCH Venture Partners	Yes	Series A
Alexandria Venture Investments	—	Series A
Eli Lilly & Company Foundation	—	Series A
Foothill Ventures	—	Series A
Formic Ventures	—	Series A
Illumina Ventures	—	Series A
Johnson & Johnson Innovation – JJDC	—	Series A
Lifespan Investments	—	Series A
Medical Excellence Capital	—	Series A
Vertex Ventures HC	—	Series A